Search results
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
Digital Journal· 7 days agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven mechanisms that contribute to the broad efficacy of the vaccine ...
Novavax Stock Just Tripled. Is It Too Late to Buy? | The Motley Fool
The Motley Fool· 6 days agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NVAX -4.30%) stock has...
Genetics Played a Role in Blood Clots Linked to COVID-19 Shots
Time Magazine· 5 days agoAdenovirus-based vaccines, like the J&J and AstraZeneca shots that were later pulled from the...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 2 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
Does Medicare Cover the RSV Vaccine?
US News Health· 7 days agoCDC recommends vaccination for higher-risk populations. Two vaccines – Arexvy and Abrysvo – are currently approved by the FDA for those ages 60 and older and offers protection ...
Post-pandemic problems: These stocks are still down more than 50 percent from their Covid highs
Bankrate via Yahoo Finance· 6 days agoIts shares traded as low as $3.55 in December 2022. Covid high stock price: $376.83 Current stock...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 3 days agoDemand for COVID products has been declining significantly over the past year. Pfizer experienced an 88% decline in revenue for its popular COVID vaccine...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 22 hours agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...
New Covid Variants Have Emerged Called FLiRT | Newswise
Newswise· 5 days agoTwo new COVID-19 variants nicknamed FLiRT are circulating. The new strains are sub variants of the omicron variant. The FLiRT strains have the same pattern as previous mutations and early evidence ...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 7 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
